arrow_back Trending Legislation
Share share

Tax Credits for Small Businesses on Drug Threat Research

This bill introduces new tax credits for small businesses conducting research aimed at combating drug threats like fentanyl and methamphetamine. The goal is to encourage the development of new methods for prevention, treatment, and intervention related to these substances, potentially improving public safety and health in communities.
Key points
Small businesses can receive a 10% tax credit for research expenses related to mitigating the effects of certain drug use.
Eligible research includes efforts to prevent, treat, or intervene in the use of specified drugs like fentanyl, methamphetamine, and emerging drugs.
The act aims to foster innovation in addressing the drug crisis, potentially leading to safer communities and better treatment options.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
To amend the Internal Revenue Code of 1986 to provide a credit to small businesses for research activities related to the mitigation of certain drug threats.
Print number: HR 6979
Sponsor: Rep. Neguse, Joe [D-CO-2]
Process start date: 2024-01-11
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Tax Credits for Small Businesses on Drug Threat Research

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 6979.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-01-11.

What are the main provisions?

Key points include:

  • Small businesses can receive a 10% tax credit for research expenses related to mitigating the effects of certain drug use.
  • Eligible research includes efforts to prevent, treat, or intervene in the use of specified drugs like fentanyl, methamphetamine, and emerging drugs.
  • The act aims to foster innovation in addressing the drug crisis, potentially leading to safer communities and better treatment options.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Neguse, Joe [D-CO-2].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Ways and Means.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

Analysis and Potential Impact of HR 6979

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Taxes Health